Enhancement of allograft acceptance by combined dexmedetomidine and rapamycin [0.03%]
右美托咪定联合雷帕霉素增强同种异体移植物的接受度
Chen-Fang Lee,Chih-Hsien Cheng,Hui-Hsin Chuang et al.
Chen-Fang Lee et al.
Background: Dexmedetomidine, an α2-adrenoceptor agonist, is known for its sedative effects and unique pharmacological mechanism. Research increasingly emphasizes its potential to modulate immune responses. Further invest...
Hemophagocytic Lymphohistiocytosis with onset of mental and behavioral disorders following allogeneic hematopoietic stem cell transplantation: A case report [0.03%]
异基因造血干细胞移植后出现精神行为异常的噬血细胞性淋巴组织细胞增生症一例报告
Heng Liu,Yaozhu Pan,Wu Tao et al.
Heng Liu et al.
Hemophagocytic lymphohistiocytosis (HLH) is a rare but highly fatal complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT), with central nervous system involvement (CNS-HLH) being exceptionally uncommon in adu...
Immunomodulation in post-transplant diabetes mellitus: Challenges and management [0.03%]
移植后糖尿病的免疫调节：挑战与管理
Hanan Maoz,Amir Elalouf
Hanan Maoz
Solid organ transplantation (SOT) in diabetic patients presents unique challenges in balancing immunosuppression, glycemic control, and the risk of infection. Post-transplant diabetes mellitus (PTDM) affects 10 %-40 % of transplant recipien...
Linking autophagy to endothelial cell immunogenicity in transplant-associated ischemia-reperfusion injury [0.03%]
缺血/再灌注损伤中移植相关自噬与内皮细胞免疫原性之间的关系研究
Meredith E Taylor,Dinesh Jaishankar,Krishnaraju Madavaraju et al.
Meredith E Taylor et al.
Background: Cold storage (CS) and ischemia-reperfusion injury (IRI) are inevitable consequences of heart transplantation (HTx), primarily affecting the microvascular endothelial cells (ECs) of donor hearts. The nutrient d...
Transplant outcomes after de novo donor specific antibody (DSA) development correlate with persistence of DSA [0.03%]
脱 novo供者特异性抗体（DSA）产生后的移植结果与DSA的持续性相关
A Jaffer,O Shaw,D Stringer et al.
A Jaffer et al.
Background: The OuTSMART trial confirmed de novo DSAs were associated with an increased risk of graft loss and rejection. In this post-hoc analysis, outcomes were analysed in 132 patients who had a DSA at the point of ran...
Hematopoietic stem cell transplantation across ABO compatibility barrier in HLA genoidentical related donor: Is it an unfavorable factor for overall survival (OS) in Tunisian patients? [0.03%]
ABO不相合在造血干细胞移植中对同基因相关供者患者总生存率(OS)有不良影响吗？-一项来自突尼斯中心的研充
Mohamed Hichem Sellami,Yesmine Boughzala,Eya Ghazouani et al.
Mohamed Hichem Sellami et al.
Benchmarking of survival following Hematopoietic Stem Cell Transplantation (HSCT) is very useful in the field of transplant medicine. It has been reported that decreased survival rates after HSCT may be affected by the ABO mismatch in some ...
HLA-specific platelet trasfusion as part of desensitization strategy in patients with donor-specific anti-HLA antibodies before stem cell transplantation [0.03%]
供者特异性抗HLA抗体阳性患者接受造血干细胞移植前血小板特异型免疫净化的研究
Giuliana Lando,Roberto Crocchiolo,Giorgia Cornacchini et al.
Giuliana Lando et al.
The presence of donor-specific anti-HLA antibodies (DSAs) in patients who are candidates for allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a recognized risk factor for delayed engraftment and mortality. In the absence of...
Natural killer cell KIR genotype and NKG2C phenotype in correlation to BKV infection following kidney transplantation [0.03%]
肾脏移植后天然杀伤细胞KIR基因型和NKG2C表型与BK病毒感染的相关性研究
Shubo Tan,Xiaobin Lin,Xueqi Li et al.
Shubo Tan et al.
Purpose: To explore the correlation between the NK cell killer immunoglobulin-like receptor (KIR) genotype, NKG2C phenotype, and BK virus (BKV) infection following kidney transplantation. ...
CXCL11 as potential predictive biomarker and therapeutic target of acute rejection after kidney transplantation [0.03%]
CXC基序趋化因子11可能是预测肾移植后急性排异反应的生物标志物和治疗靶点
Jie Zhang,Chengjun Yu,Huyu Wang et al.
Jie Zhang et al.
Kidney transplantation is the optimal treatment method for chronic kidney disease. Although the short-term and long-term survival rates of transplanted kidneys have been significantly improved with the development of immunosuppressive agent...
Diagnostic value of dd-cfDNA and CXCL-10 in kidney allograft recipients for identifying acute rejection [0.03%]
检测dd-cfDNA和CXCL-10诊断肾移植急性排斥反应的价值
Qi Yu,Yan Zhang,Zijian Gao et al.
Qi Yu et al.
Background and hypothesis: Acute rejection (AR) remains a major challenge in kidney transplantation. Current methods used to diagnose acute rejection are either invasive or not sufficiently sensitive. Thus, in this study,...